NEW YORK—An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in BP compared ...
Proportion achieving target BP increased with use of triple combo pill versus usual care at six months. TUESDAY, Aug. 14, 2018 (HealthDay News) — Treatment with a pill combining low doses of 3 ...
LONDON (AP) — BP said its earnings from April to June almost tripled from a year earlier, increasing pressure on governments to intervene as energy companies profit from high oil and natural gas ...
BP will accelerate its net-zero ambitions and devote more resources to low-carbon energy, the company said Tuesday in an earnings release. In 2021, BP posted $12.85 billion in profit compared with ...
Patients who mix a diuretic and renin-angiotensin system (RAS) inhibitor with a nonsteroidal anti-inflammatory drug (NSAID) could face a higher risk of developing acute kidney injury (AKI), a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results